货号:A569478 同义名: Cerulein;Caerulein
Ceruletide 是一种十肽,也是一种有效的胆囊收缩素受体激动剂。Ceruletide 是一种安全且有效的促胆囊收缩剂,具有直接作用于胆囊肌肉和胆管的痉挛效应。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Cholecystokinin octapeptide (cholecystokinin-8) is found in the peripheral tissue and central nervous system (CNS). It is becoming clear that cholecystokinin-8 sulphate may function as a neurotransmitter or neuromodulator in the CNS. Thus, cholecystokinin-8 sulphate is released from synaptic vesicles in a calcium-dependent manner, binds to specific high affinity cholecystokinin receptors and exerts primarily excitatory effect on CNS neurons. One potential role that has been proposed for cholecystokinin is the modulation of central opiate nociceptive mechanism. Cholecystokinin receptors are generally divided into two classes, cholecystokinin-A (alimentary) and cholecystokin- in-B (brain)[3]. Caerulein is a decapeptide isolated from frog skin, which has been shown to possess the same biological and pharmacological activities as cholecystokinin-8[3]. Ceruletide in supramaximal but not in physiological doses activated NF-kappaB/Rel in vitro. This activation might induce a self-defending genetic program before the onset of cellular injury, which might prevent higher degrees of damage of pancreatic acinar cells after secretagogue hyperstimulation[4]. Ceruletide serum bile acid (SBA) stimulation circumvented exogenous and endogenous influences associated with postprandial (PP) SBA stimulation. Ceruletide SBA stimulation might perform as well as PP SBA stimulation in dogs with portosystemic shunt (PSS) and be more sensitive for the detection of hepatic dysfunction in dogs with upper respiratory disease (URD)[5]. Ceruletide (0.4-0.5 mcg/kg, i.v.; 3-4 mcg/kg, s.c.) resulted in emesis and evacuation of the bowel in the intact conscious dog, and recovery was complete 15 - 30 min after i. v. administration and 2 - 4h after s.c. administration. Ceruletide (5 - 15 ng/kg, i.v.) showed a marked spasmogenic effect on the pylorus of rats. Ceruletide also reduced blood pressure in anesthetized dogs[6]. |
Dose | Mice: 1 μg/kg - 300 μg/kg[3] (i.p.); 0.01 mg/kg - 0.1 mg/kg[4] (s.c.) |
Administration | i.p. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03748667 | - | Not yet recruiting | December 2020 | United States, California ... 展开 >> San Francisco Veterans Affairs Medical Center. University of California Not yet recruiting San Francisco, California, United States, 94121 Contact endoresection@me.com Principal Investigator: Tonya Kaltenbach United States, North Carolina University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact mcgills@email.unc.edu Principal Investigator: Sarah McGill Japan National Cancer Center Not yet recruiting Tokyo, Japan, 104-0045 Contact tasakamo529@gmail.com Principal Investigator: Taku Sakamoto Spain Hospital Clínico Universitario Lozano Blesa Not yet recruiting Zaragoza, Aragón, Spain, 50009 Contact angel.ferrandez@telefonica.net Principal Investigator: Ángel Ferrández Hospital Universitari Germans Trias i Pujol (Can Ruti) Not yet recruiting Badalona, Cataluña, Spain, 08916 Contact hugoikuo@gmail.com Principal Investigator: Hugo Uchima Hospital Clínic de Barcelona Not yet recruiting Barcelona, Cataluña, Spain, 08036 Contact MPELLISE@clinic.cat Principal Investigator: Maria Pellisé Sub-Investigator: Miriam Cuatrecasas Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Not yet recruiting Barcelona, Cataluña, Spain, 08036 Contact JCAMPS@clinic.cat Sub-Investigator: Jordi Camps Althaia. Xarxa Assistencial Universitària de Manresa Not yet recruiting Manresa, Cataluña, Spain, 08243 Contact orosinol@althaia.cat Sub-Investigator: Òria Rosiñol Hospital Universitario y Politécnico de La Fe Not yet recruiting Valencia, Comunidad Valenciana, Spain, 46009 Contact mbustamantebalen@gmail.com Principal Investigator: Marco Bustamante Complejo Hospitalario de Navarra Not yet recruiting Pamplona, Navarra, Spain, 31008 Contact edualbeniz@hotmail.com Principal Investigator: Eduardo Albéniz Hospital Ramón y Cajal Not yet recruiting Madrid, Spain, 28034 Contact enrodesan@gmail.com Principal Investigator: Enrique Rodríguez Hospital 12 de Octubre Not yet recruiting Madrid, Spain, 28041 Contact josecarlos.marin@salud.madrid.org Principal Investigator: José Carlos Marín 收起 << | |
NCT01491178 | - | Completed | - | - | |
NCT02808403 | - | Recruiting | April 30, 2022 | - | |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.74mL 0.15mL 0.07mL |
3.70mL 0.74mL 0.37mL |
7.39mL 1.48mL 0.74mL |
CAS号 | 17650-98-5 |
分子式 | C58H73N13O21S2 |
分子量 | 1352.405 |
别名 | Cerulein;Caerulein;CCRIS-3063;FI-6934 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Store in freezer, under -20°C |
溶解度 |
DMSO: 105 mg/mL(77.64 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 2.5 mg/mL(1.85 mM),配合低频超声助溶 DMF: 15 mg/mL(11.09 mM),配合低频超声助溶 |
动物实验配方 |